The Synthetic & Engineering Biology British-Swiss Summit, held in May 2024 and formally opened by H.E. Markus Leitner, Ambassador of Switzerland to the United Kingdom, brought together over 25 representatives from academia, industry, and government bodies from the UK and Switzerland.
The UK Bioindustry Association (BIA) has today joined the European Biosolutions Coalition, adding UK representation to this influential group. The European Biosolutions Coalition is an initiative established by several industry organisations to elevate the prominence of biosolutions on the European agenda.
Last week saw the key parties launch their general election manifestoes. This week sees a set piece hosting debate with the core parties talking about their approach to science and innovation at a live hustings at the Royal Society.
With the Prime Minister calling a snap election set for 4 July, the BIA’s attention has turned to preparing for the next government. Meanwhile, Parliament Day, our flagship day of parliamentary engagement, has been postponed to the autumn. Official engagements with civil servants have also been restricted in accordance with the pre-election period of sensitivity.
Featured in BIA's Deep Biotech report, Epoch Biodesign aims to revolutionize plastic waste management by creating tailor-made enzymes that efficiently depolymerize a wide range of plastics into recyclable materials, offering a circular solution to tackle plastic pollution and promote sustainability.
Solena Materials is a pioneering biotech company spun out from Imperial College London, specialising in the development of computationally designed synthetic protein materials, originally featured in BIA's Deep Biotech report on disruptive innovation for global sustainability.
A spin-out from Oxford University, Moa Technology is developing next-generation herbicides to tackle a growing crisis in agriculture. Read more in BIA's Deep Biotech report on disruptive innovation for global sustainability.
Professor Paul Freemont, Faculty of Medicine, Department of Infectious Disease at Imperial College shares insights from his speech at the 10 Downing Street reception. Discover the dynamic landscape of UK engineering biology, where innovation meets sustainability, and explore the vibrant ecosystem of pioneering companies poised to revolutionize industries worldwide.
Evonetix is developing a new tool that lets researchers build the building blocks of life – genes – faster and easier than ever before. This could lead to breakthroughs in medicine and agriculture. Read more in BIA's Deep Biotech report on disruptive innovation for global sustainability.
With a general election widely expected to be called later this year, the BIA’s long-established relationships with senior parliamentarians have been of particular importance this quarter. From launching the Labour Party’s Life Science Sector Strategy in Stevenage in January to hosting Science Minister Andrew Griffith MP at our Gala Dinner, we continue to represent the sector at the highest levels.
In this blog, Maddie Cass, Senior Policy and Public Affairs Executive at the BIA, shares insights on the Innovation & Research Caucus (IRC) recent report, which examines the current state of the UK's non-health engineering biology infrastructure.
Herbie Lambden, Senior Policy and Public Affairs Executive at the BIA, provides a rundown of the BIA Committee Summit, which took place in Westminster on 21 February.
The BIA has named this frontier of science Deep Biotech. Our brand-new report, "Deep Biotech: Disruptive innovation for global sustainability" highlights how deep biotech is key to creating a sustainable UK bioeconomy and making the UK a science superpower that benefits all.
Deep Biotech encompasses innovative companies harnessing the power of engineering biology to tackle humanity's most pressing challenges, from environmental pollution to climate change. From cultivating meat without animals to crafting bio-based materials that replace harmful plastics, Deep Biotech offers a sustainable roadmap for a greener future.
The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.
The Bio-Based and Biodegradable Industries Association (BBIA) and The BioIndustry Association (BIA) enter a mutual membership agreement to strengthen collaboration and support each other's work and member communities.
Deep Biotech applies the power of biotechnology to address some of humanity's biggest challenges. The life sciences industry has ushered in many ground-breaking innovations in health. In response to the challenge of global warming the same technologies that delivered life-saving therapeutics are being harnessed to disrupt traditional industries and reduce environmental damage.
